Nu.Q® Discover epigenetic profiling for target identification to validation in clinical studies
Nu.Q® Discover epigenetic profiling for target identification to validation in clinical studies
Media & Downloads

Nu.Q® H3.1 for Cell Death Assessment

October 01, 2026
Nu.Q® Discover epigenetic profiling for target identification to validation in clinical studies
Nu.Q® Discover epigenetic profiling for target identification to validation in clinical studies

The Nu.Q® H3.1 immunoassay quantitatively measures nucleosomes containing histone H3.1, providing a sensitive and convenient approach for assessing cell death in biological samples.

Learn more about Nu.Q® Discover

Download our guide to find out more about this assay.

Volition